Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hari Kumar Ondiveeran

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Microcirculation (New York, N.Y. : 1994)|February 25, 2005
Pentastarch in a balanced solution reduces hepatic leukocyte recruitment in early sepsisHari Kumar Ondiveeran, Alison E Fox-Robichaud
Idrugs : the Investigational Drugs Journal|June 16, 2004
Drug evaluation: E-5564Hari Kumar Ondiveeran, Alison Fox-Robichaud
Idrugs : the Investigational Drugs Journal|July 16, 2003
Tifacogin (Chiron Corp/Pharmacia Corp)Niv Sne, Hari Kumar Ondiveeran, Alison Fox-Robichaud
Shock (Augusta, Ga.)|May 24, 2008
Nitric oxide donors in sepsis: a systematic review of clinical and in vivo preclinical dataFrancois Lamontagne, Maureen Meade, Hari Kumar Ondiveeran, et al.
Critical Care Medicine|April 25, 2008
Ron receptor tyrosine kinase-dependent hepatic neutrophil recruitment and survival benefit in a murine model of bacterial peritonitisCharles C Caldwell, Andre Martignoni, Mike A Leonis, et al.
American Journal of Respiratory and Critical Care Medicine|January 11, 2005
Lung development and susceptibility to ventilator-induced lung injuryAlik Kornecki, Shinya Tsuchida, Hari Kumar Ondiveeran, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Microcirculation (New York, N.Y. : 1994)|February 25, 2005
Pentastarch in a balanced solution reduces hepatic leukocyte recruitment in early sepsisHari Kumar Ondiveeran, Alison E Fox-Robichaud
Idrugs : the Investigational Drugs Journal|June 16, 2004
Drug evaluation: E-5564Hari Kumar Ondiveeran, Alison Fox-Robichaud
Idrugs : the Investigational Drugs Journal|July 16, 2003
Tifacogin (Chiron Corp/Pharmacia Corp)Niv Sne, Hari Kumar Ondiveeran, Alison Fox-Robichaud
Shock (Augusta, Ga.)|May 24, 2008
Nitric oxide donors in sepsis: a systematic review of clinical and in vivo preclinical dataFrancois Lamontagne, Maureen Meade, Hari Kumar Ondiveeran, et al.
Critical Care Medicine|April 25, 2008
Ron receptor tyrosine kinase-dependent hepatic neutrophil recruitment and survival benefit in a murine model of bacterial peritonitisCharles C Caldwell, Andre Martignoni, Mike A Leonis, et al.
American Journal of Respiratory and Critical Care Medicine|January 11, 2005
Lung development and susceptibility to ventilator-induced lung injuryAlik Kornecki, Shinya Tsuchida, Hari Kumar Ondiveeran, et al.
Pageof 1